ArticleScience advances2026

The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.

Kelsey H Fisher-Wellman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.